TY - JOUR
T1 - Hot water extracted Lycium barbarum and Rehmannia glutinosa inhibit liver inflammation and fibrosis in rats
AU - Wu, Po Shan
AU - Wu, Shu Ju
AU - Tsai, Ya-Hui
AU - Lin, Yun Ho
AU - Chao, Jane C J
PY - 2011
Y1 - 2011
N2 - Polysaccharide-rich Lycium barbarum and Rehmannia glutinosa have been considered to have immune-modulating activity. This study investigated the effects of water extracted Lycium barbarum and Rehmannia glutinosa (HE) on carbon tetrachloride (CCl 4)-induced liver injury in rats. Male Sprague-Dawley rats were randomly divided into: normal diet + peritoneal injection of olive oil (control), normal diet + CCl 4 injection (CCl 4), 1 × HE (0.05% HE for each) + CCl 4 (1 × HE), and 3 × HE (0.15% HE for each) + CCl 4 (3 × HE) groups. Rats were injected with 40% CCl 4 at a dose of 0.75 ml/kg body weight once a week for seven weeks, one week after herbal extract treatment. After eight week herbal extract treatment, pathohistological examination showed that both 1× and 3 × HE treatments diminished necrotic hepatocytes, chemoattraction of inflammatory cells, and liver fibrosis. Both 1× and 3 × HE treatments decreased plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and reduced hepatic levels of pro-inflammatory cytokines tumor necrosis factor-α and interleukin-1β compared to CCl 4 treatment alone. The 1 × HE treatment increased hepatic anti-inflammatory cytokine IL-10 levels. Both the 1× and 3 × HE treatments suppressed liver fibrosis biomarkers transforming growth factor-β1 and hydroxyproline. Therefore, treatment with water extracted Lycium barbarum and Rehmannia glutinosa (0.05% and 0.15% for each) for eight weeks protects against necrotic damage, indicated by decreases in plasma ALT and AST activities, and suppresses liver fibrosis by down-regulation of liver inflammation in rats with CCl4-induced liver injury.
AB - Polysaccharide-rich Lycium barbarum and Rehmannia glutinosa have been considered to have immune-modulating activity. This study investigated the effects of water extracted Lycium barbarum and Rehmannia glutinosa (HE) on carbon tetrachloride (CCl 4)-induced liver injury in rats. Male Sprague-Dawley rats were randomly divided into: normal diet + peritoneal injection of olive oil (control), normal diet + CCl 4 injection (CCl 4), 1 × HE (0.05% HE for each) + CCl 4 (1 × HE), and 3 × HE (0.15% HE for each) + CCl 4 (3 × HE) groups. Rats were injected with 40% CCl 4 at a dose of 0.75 ml/kg body weight once a week for seven weeks, one week after herbal extract treatment. After eight week herbal extract treatment, pathohistological examination showed that both 1× and 3 × HE treatments diminished necrotic hepatocytes, chemoattraction of inflammatory cells, and liver fibrosis. Both 1× and 3 × HE treatments decreased plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and reduced hepatic levels of pro-inflammatory cytokines tumor necrosis factor-α and interleukin-1β compared to CCl 4 treatment alone. The 1 × HE treatment increased hepatic anti-inflammatory cytokine IL-10 levels. Both the 1× and 3 × HE treatments suppressed liver fibrosis biomarkers transforming growth factor-β1 and hydroxyproline. Therefore, treatment with water extracted Lycium barbarum and Rehmannia glutinosa (0.05% and 0.15% for each) for eight weeks protects against necrotic damage, indicated by decreases in plasma ALT and AST activities, and suppresses liver fibrosis by down-regulation of liver inflammation in rats with CCl4-induced liver injury.
KW - Cytokines
KW - Herbal Extract
KW - Hydroxyproline
KW - Liver Injury
KW - Polysaccharides
KW - Transforming Growth Factor-β1
UR - http://www.scopus.com/inward/record.url?scp=81155153692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81155153692&partnerID=8YFLogxK
U2 - 10.1142/S0192415X11009482
DO - 10.1142/S0192415X11009482
M3 - Article
C2 - 22083989
AN - SCOPUS:81155153692
SN - 0192-415X
VL - 39
SP - 1173
EP - 1191
JO - American Journal of Chinese Medicine
JF - American Journal of Chinese Medicine
IS - 6
ER -